Enanta Pharmaceuticals reported $202K in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Amgen AMGN:US $ 31989M 112M
Anika Therapeutics ANIK:US $ 0.14M 0M
AstraZeneca AZN:LN 387M 59M
Biogen BIIB:US $ 0.1M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Clovis Oncology CLVS:US $ 0.13M 0.01M
GlaxoSmithKline GSK:LN 1347M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 1.02M 0M
Insmed INSM:US $ 1.18M 32K
Karyopharm Therapeutics KPTI:US $ 8K 0
Ligand Pharmaceuticals LGND:US $ 0.02M 0M
Marinus Pharmaceuticals MRNS:US $ 0.04M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 901M 12M
Novavax NVAX:US $ 0.76M 0.01M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Vertex Pharmaceuticals VRTX:US $ 2.56M 0.03M
Vital Therapies VTL:US $ 0M 0M
YTE INCY:US $ 0.22M 0M